Cosmetic cross-reference

Glutamic Acid

CAS 56-86-0

Glutamic Acid (CAS 56-86-0) is a Phase 3 pharmaceutical compound with 27 bioactivity targets and 2 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
48
SOURCE DrugCentral
Adverse signals
2
SOURCE IUPHAR/BPS
PubMed IDs
16
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Glutamic Acid
CAS Number
56-86-0
UNII
3KX376GY7L
InChIKey
WHUUTDBJXJRKMK-VKHMYHEASA-N
ChEMBL ID
CHEMBL575060
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
glutamate
natural product
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3
Late-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL575060 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 48 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- EC50 19779.175698324023 nM 156 -
- Ki 5053.974411764706 nM 92 -
- IC50 10193.532063492064 nM 54 -
- AC50 30158.23741935484 nM 32 -
- Potency 13790.855555555556 nM 8 -
Adenosine receptor A3
GPCR
IC50 6.21 - Homo sapiens
Glutathione reductase, mitochondrial
Enzyme
Ki 4.37 - Homo sapiens
Glutamate receptor 1
Ion channel
Ki 5.87 - Homo sapiens
Glutamate receptor ionotropic, kainate 1
Ion channel
Ki 6.15 - Homo sapiens
Glutamate receptor 2
Ion channel
Ki 6.03 - Homo sapiens
Metabotropic glutamate receptor 1
GPCR
Ki 6.6 - Homo sapiens
Glutamate dehydrogenase 1, mitochondrial
Enzyme
- - - Homo sapiens
Glutamate dehydrogenase 2, mitochondrial
Enzyme
- - - Homo sapiens
Glutamate receptor ionotropic, kainate 5
Ion channel
Ki 6.15 - Homo sapiens
Metabotropic glutamate receptor 5
GPCR
Ki 6.41 - Homo sapiens
Metabotropic glutamate receptor 4
GPCR
Ki 5.85 - Homo sapiens
Glutamate receptor 4
Ion channel
Ki 6.06 - Homo sapiens
Glutamate receptor ionotropic, kainate 2
Ion channel
Ki 5.96 - Homo sapiens
Glutamate receptor ionotropic, kainate 3
Ion channel
Ki 6.1 - Homo sapiens
Metabotropic glutamate receptor 7
GPCR
EC50 5.93 - Homo sapiens
Metabotropic glutamate receptor 6
GPCR
EC50 5.31 - Homo sapiens
Metabotropic glutamate receptor 2
GPCR
EC50 6.54 - Homo sapiens
Excitatory amino acid transporter 1
Transporter
Ki 4.46 - Homo sapiens
Excitatory amino acid transporter 2
Transporter
Ki 4.21 - Homo sapiens
Excitatory amino acid transporter 3
Transporter
Ki 7.29 - Homo sapiens
Glutamate receptor 2
Ion channel
Ki 6.55 - Rattus norvegicus
Glutamate receptor 3
Ion channel
Ki 6.595 - Homo sapiens
Glutamate receptor ionotropic, kainate 4
Ion channel
Ki 7.738 - Homo sapiens
Metabotropic glutamate receptor 3
GPCR
Ki 7.4 - Homo sapiens
Metabotropic glutamate receptor 8
GPCR
IC50 5.7 - Homo sapiens
Glutamate receptor ionotropic, NMDA 1
Ion channel
EC50 5.54 - Rattus norvegicus
Glutamate receptor ionotropic, kainate 2
Ion channel
Ki 5.48 - Rattus norvegicus
Glutamate receptor ionotropic, kainate 1
Ion channel
Ki 6.85 - Rattus norvegicus
Metabotropic glutamate receptor 4
GPCR
EC50 4.92 - Rattus norvegicus
Metabotropic glutamate receptor 6
GPCR
EC50 4.8 - Rattus norvegicus
Glutamate receptor 1
Ion channel
EC50 4.46 - Rattus norvegicus
Glutamate receptor 3
Ion channel
EC50 4 - Rattus norvegicus
Glutamate receptor 4
Ion channel
EC50 4.77 - Rattus norvegicus
Glutamate receptor ionotropic, kainate 3
Ion channel
Ki 6.31 - Rattus norvegicus
Glutamate racemase
Enzyme
Ki 4.55 - Lactobacillus fermentum
Metabotropic glutamate receptor 8
GPCR
Ki 5.47 - Rattus norvegicus
Metabotropic glutamate receptor 8
GPCR
EC50 7.66 - Mus musculus
Metabotropic glutamate receptor 5
GPCR
EC50 5.36 - Rattus norvegicus
Metabotropic glutamate receptor 1
GPCR
EC50 5 - Rattus norvegicus
Metabotropic glutamate receptor 2
GPCR
EC50 5.4 - Rattus norvegicus
Metabotropic glutamate receptor 3
GPCR
EC50 5.52 - Rattus norvegicus
Glutamate racemase
Enzyme
Ki 5.24 - Helicobacter pylori (strain ATCC 700392 / 26695)
Excitatory amino acid transporter 4
Transporter
IC50 4.89 - Rattus norvegicus
SOURCE DrugCentral 2 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Toxic epidermal necrolysis 21 76.155 10044223
Foetal growth restriction 15 66.301 10070531

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE IUPHAR/BPS 19 interactions

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

TargetAction AffinityPubMed
mGlu 1 receptor
GRM1
Agonist 4.800000190734863 pEC50 10443583
mGlu 1 receptor
Grm1
Full agonist 6.4 pKi 12695537|11080213
mGlu 2 receptor
GRM2
Agonist 4.699999809265137 pEC50 10443583
mGlu 2 receptor
Grm2
Full agonist 5.4 pKi 8022410|10652549
mGlu 2 receptor
GRM2
Full agonist 4.9 pKi 10530814
mGlu 3 receptor
GRM3
Agonist 5.300000190734863 pEC50 10443583
mGlu 3 receptor
GRM3
Full agonist 7.4 pKi 10530814
mGlu 3 receptor
Grm3
Full agonist 6.4 pKi 10884552
mGlu 4 receptor
GRM4
Agonist 4.699999809265137 pEC50 10443583
mGlu 4 receptor
Grm4
Full agonist 4.9 pKi 9144638|10187777|1361913|9357538
mGlu 5 receptor
GRM5
Agonist 5.0 pEC50 10443583
mGlu 5 receptor
Grm5
Full agonist 6.1 pIC50 11080213
mGlu 6 receptor
GRM6
Agonist 4.800000190734863 pEC50 10443583
mGlu 6 receptor
Grm6
Full agonist 4.4 pEC50 9833633
mGlu 6 receptor
GRM6
Full agonist 5.2 pEC50 9144651
mGlu 7 receptor
GRM7
Agonist 3.0 pEC50 10443583
mGlu 7 receptor
GRM7
Full agonist 3.1 pKi 11138847
mGlu 8 receptor
GRM8
Agonist 4.900000095367432 pEC50 10443583
mGlu 8 receptor
GRM8
Full agonist 5.0 pIC50 9473604|10216218
SOURCE NLM RxNorm 5 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
glutamic acid 25916 SU MTHSPL
Glutamic Acid 25916 SU MTHSPL
GLUTAMIC ACID 25916 SU MTHSPL
glutamic acid 25916 PIN RXNORM
glutamate 70602 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Glutamic Acid used for in pharmaceutical contexts?

Glutamic Acid (CAS 56-86-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Glutamic Acid?

Glutamic Acid has 2 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Toxic epidermal necrolysis, Foetal growth restriction. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Glutamic Acid also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for L-Glutamic Acid with EU status "permitted".

What clinical phase is Glutamic Acid in?

Glutamic Acid is rendered with ChEMBL max phase 3.

What bioactivity targets are documented for Glutamic Acid?

Glutamic Acid has 48 bioactivity rows in this page query. Rendered target entries include Adenosine receptor A3, Glutathione reductase, mitochondrial, Glutamate receptor 1, Glutamate receptor ionotropic, kainate 1, Glutamate receptor 2.